Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results.

PubWeight™: 1.17‹?› | Rank: Top 10%

🔗 View Article (PMID 16989902)

Published in Ophthalmology on September 20, 2006

Authors

Henry L Hudson1, Stephen S Lane, Jeffrey S Heier, R Doyle Stulting, Lawrence Singerman, Paul R Lichter, Paul Sternberg, David F Chang, IMT-002 Study Group

Author Affiliations

1: Retina Centers, Tucson, Arizona, USA.

Articles by these authors

(truncated to the top 100)

Ranibizumab for neovascular age-related macular degeneration. N Engl J Med (2006) 30.63

Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med (2006) 20.84

Intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg (2005) 10.99

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology (2009) 6.44

WormBase: a cross-species database for comparative genomics. Nucleic Acids Res (2003) 5.28

Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology (2010) 4.09

Standardized analyses of correction of astigmatism by laser systems that reshape the cornea. J Refract Surg (2006) 3.95

A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration. Ophthalmology (2009) 3.76

Risk assessment for ectasia after corneal refractive surgery. Ophthalmology (2007) 3.47

Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina (2008) 2.72

Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis (2002) 2.53

Oct-based interpretation of the vitreomacular interface and indications for pharmacologic vitreolysis. Retina (2013) 2.49

Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. Hum Mol Genet (2005) 2.32

Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study. Am J Ophthalmol (2012) 2.30

Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Radic Biol Med (2002) 2.22

Risk factors and prognosis for corneal ectasia after LASIK. Ophthalmology (2003) 2.21

Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol (2002) 2.20

Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors. Ophthalmology (2008) 2.20

Mutations in TCF8 cause posterior polymorphous corneal dystrophy and ectopic expression of COL4A3 by corneal endothelial cells. Am J Hum Genet (2005) 2.20

Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13. Ophthalmology (2004) 2.19

The effect of donor age on corneal transplantation outcome results of the cornea donor study. Ophthalmology (2008) 2.19

A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. Ophthalmology (2006) 2.17

Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab. Br J Ophthalmol (2013) 2.14

Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration. Ophthalmology (2013) 2.13

ASCRS White Paper: What is the association between clear corneal cataract incisions and postoperative endophthalmitis? J Cataract Refract Surg (2006) 2.10

Incidence of post-cataract endophthalmitis at Aravind Eye Hospital: outcomes of more than 42,000 consecutive cases using standardized sterilization and prophylaxis protocols. J Cataract Refract Surg (2009) 2.09

Delayed reactivation of presumed adenoviral subepithelial infiltrates after laser in situ keratomileusis. Cornea (2004) 2.02

Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma. PLoS Genet (2012) 2.00

Keratoconus and corneal ectasia after LASIK. J Cataract Refract Surg (2005) 1.98

Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11. Ophthalmology (2004) 1.96

Donor age and corneal endothelial cell loss 5 years after successful corneal transplantation. Specular microscopy ancillary study results. Ophthalmology (2008) 1.94

Accuracy of intraocular lens power prediction using the Hoffer Q, Holladay 1, Holladay 2, and SRK/T formulas. J Cataract Refract Surg (2006) 1.93

Five-year follow-up optic disc findings of the Collaborative Initial Glaucoma Treatment Study. Am J Ophthalmol (2009) 1.83

Oxidation of glutathione and cysteine in human plasma associated with smoking. Free Radic Biol Med (2003) 1.82

Asymmetric keratoconus attributed to eye rubbing. Cornea (2004) 1.78

Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy. Am J Ophthalmol (2003) 1.74

Age-related retinopathy in NRF2-deficient mice. PLoS One (2011) 1.71

Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology (2011) 1.70

Clinicopathologic findings in choroidal melanomas after failed transpupillary thermotherapy. Am J Ophthalmol (2003) 1.69

Anterior chamber intraocular lens (ACIOL) placement after pars plana lensectomy in pediatric Marfan syndrome. J AAPOS (2005) 1.68

Prevention, diagnosis, and management of acute postoperative bacterial endophthalmitis. J Cataract Refract Surg (2011) 1.66

Assessing the need for posterior sclerotomy at the time of filtering surgery in patients with Sturge-Weber syndrome. Ophthalmology (2003) 1.63

The effect of alpha1-adrenergic receptor antagonist tamsulosin (Flomax) on iris dilator smooth muscle anatomy. Ophthalmology (2010) 1.59

Performance of presbyopia-correcting intraocular lenses in distance optical bench tests. J Cataract Refract Surg (2009) 1.59

Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol (2005) 1.53

Corneal ectasia after photorefractive keratectomy. J Cataract Refract Surg (2006) 1.49

Attachment to and penetration of conventional and silicone hydrogel contact lenses by Fusarium solani and Ulocladium sp. in vitro. Cornea (2007) 1.47

Dissatisfaction after multifocal intraocular lens implantation. J Cataract Refract Surg (2009) 1.47

Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration. Proc Natl Acad Sci U S A (2011) 1.47

Oxidant-induced apoptosis in human retinal pigment epithelial cells: dependence on extracellular redox state. Invest Ophthalmol Vis Sci (2005) 1.47

Racial disparities in the use of ancillary testing to evaluate individuals with open-angle glaucoma. Arch Ophthalmol (2012) 1.46

Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: I. Ophthalmic findings from a randomized clinical trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9. Arch Ophthalmol (2004) 1.43

Clinical and microbiological characteristics of fungal keratitis in the United States, 2001-2007: a multicenter study. Ophthalmology (2011) 1.43

Ophtec iris reconstruction lens United States clinical trial phase I. Ophthalmology (2004) 1.42

Normal-tension glaucoma history. Ophthalmology (2002) 1.39

Validation of the Ectasia Risk Score System for preoperative laser in situ keratomileusis screening. Am J Ophthalmol (2008) 1.38

Phacoemulsification versus manual small-incision cataract surgery for white cataract. J Cataract Refract Surg (2010) 1.37

Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration. Ophthalmology (2006) 1.37

Pre-mRNA splicing and retinitis pigmentosa. Mol Vis (2006) 1.32

Complication rates of phacoemulsification and manual small-incision cataract surgery at Aravind Eye Hospital. J Cataract Refract Surg (2012) 1.31

Corneal ectasia after laser in situ keratomileusis in patients without apparent preoperative risk factors. Cornea (2006) 1.31

Optical performance of 3 intraocular lens designs in the presence of decentration. J Cataract Refract Surg (2005) 1.30

Trends in fungal keratitis in the United States, 2001 to 2007. Ophthalmology (2010) 1.30

Implementation of a color-capable optofluidic microscope on a RGB CMOS color sensor chip substrate. Lab Chip (2010) 1.28

Essential roles of the PI3 kinase/Akt pathway in regulating Nrf2-dependent antioxidant functions in the RPE. Invest Ophthalmol Vis Sci (2008) 1.28

Long-term trends in intraocular pressure after pars plana vitrectomy. Retina (2011) 1.26

SD-OCT analysis of regional epithelial thickness profiles in keratoconus, postoperative corneal ectasia, and normal eyes. J Refract Surg (2013) 1.24

Change in intraocular pressure measurements after LASIK the effect of the refractive correction and the lamellar flap. Ophthalmology (2005) 1.24

Mitochondrial DNA polymorphism A4917G is independently associated with age-related macular degeneration. PLoS One (2008) 1.23

The effect of donor age on penetrating keratoplasty for endothelial disease: graft survival after 10 years in the Cornea Donor Study. Ophthalmology (2013) 1.23

Standardized graphs and terms for refractive surgery results. J Refract Surg (2011) 1.23

Corneal ectasia after excimer laser keratorefractive surgery: histopathology, ultrastructure, and pathophysiology. Ophthalmology (2008) 1.22

The prognostic significance of a system for classifying mechanical injuries of the eye (globe) in open-globe injuries. J Trauma (2003) 1.21

The collaborative initial glaucoma treatment study: baseline visual field and test-retest variability. Invest Ophthalmol Vis Sci (2003) 1.20

Increased glutathione synthesis through an ARE-Nrf2-dependent pathway by zinc in the RPE: implication for protection against oxidative stress. Invest Ophthalmol Vis Sci (2006) 1.19

Primary endpoint results of a phase II study of vascular endothelial growth factor trap-eye in wet age-related macular degeneration. Ophthalmology (2011) 1.18

Depression and mood indicators in newly diagnosed glaucoma patients. Am J Ophthalmol (2007) 1.12

Multiplex cytokine analysis reveals elevated concentration of interleukin-8 in glaucomatous aqueous humor. Invest Ophthalmol Vis Sci (2010) 1.12

Keratoconus and corneal ectasia after LASIK. J Refract Surg (2005) 1.11

Screening for Keratoconus and Related Ectatic Corneal Disorders. Cornea (2015) 1.09

Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC Study. Ophthalmology (2012) 1.09

Cataract extraction in the collaborative initial glaucoma treatment study: incidence, risk factors, and the effect of cataract progression and extraction on clinical and quality-of-life outcomes. Arch Ophthalmol (2006) 1.08

Antioxidant supplements prevent oxidation of cysteine/cystine redox in patients with age-related macular degeneration. Am J Ophthalmol (2005) 1.08

Ocular argyrosis after long-term self-application of eyelash tint. Am J Ophthalmol (2006) 1.07

Factors associated with intraocular pressure before and during 9 years of treatment in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology (2007) 1.07

The NEIGHBOR consortium primary open-angle glaucoma genome-wide association study: rationale, study design, and clinical variables. J Glaucoma (2013) 1.06

Blast eye injuries: a review for first responders. Disaster Med Public Health Prep (2010) 1.06

Visual rehabilitation and outcomes for ectasia after corneal refractive surgery. J Cataract Refract Surg (2008) 1.05

Endothelial cell density to predict endothelial graft failure after penetrating keratoplasty. Arch Ophthalmol (2010) 1.05

Incidence, outcomes, and risk factors for retreatment after wavefront-optimized ablations with PRK and LASIK. J Refract Surg (2009) 1.05

Avellino corneal dystrophy after LASIK. Ophthalmology (2004) 1.04

Fusarium keratitis and contact lens wear: facts and speculations. Med Mycol (2008) 1.03

Early rotational stability of the longer Staar toric intraocular lens: fifty consecutive cases. J Cataract Refract Surg (2003) 1.02

Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes. Ophthalmology (2003) 1.01

Baseline factors related to endothelial cell loss following penetrating keratoplasty. Arch Ophthalmol (2011) 1.01

Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series. Ophthalmology (2002) 1.00

Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration. Am J Ophthalmol (2006) 1.00

Comparing immersion ultrasound with partial coherence interferometry for intraocular lens power calculation. Ophthalmic Surg Lasers Imaging (2008) 0.99

Trends in use of ancillary glaucoma tests for patients with open-angle glaucoma from 2001 to 2009. Ophthalmology (2012) 0.98

Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization study. Ophthalmology (2005) 0.98